drugset / Trial / NCT01890057

The Dose of Sugammadex for Rapid Reversal of Profound Neuromuscular Block in Young and Elderly Patients

NCT01890057

Completed 44 enrolled Severance Hospital
Non-randomizedParallel-groupDouble-blind

Summary

To find out the dose of sugammadex for recovery of the TOF ratio to 0.9 within 2 minutes from profound rocuronium-induced neuromuscular block in young and elderly adult patients.

Timeline

Start
2013-06
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sugammadex Other / unclassified

Indications

No indication recorded.